Simultaneous detection of the genus Brucella by combinatorial PCR.

Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
Japanese journal of infectious diseases (Impact Factor: 1.51). 06/2007; 60(2-3):137-9.
Source: PubMed

ABSTRACT We have developed a combinatorial polymerase chain reaction (PCR) procedure to identify four major species of the genus Brucella simultaneously. Four pairs of primers targeting the genes encoding a cell surface protein (BCSP31) and outer membrane proteins (omp2b, omp2a and omp31) were prepared. PCR using these primers gave rise to specific patterns of amplification for each Brucella spp. examined in this study. B. abortus could be identified when fragments of BCSP31 and omp2b/2a were amplified by B. abortus-specific primers. B. melitensis could be identified by the amplification of fragments of BCSP31, omp2b/2a and omp31 using pair of primers B4/B5, JRF/JPR-ab and omp31. Identification of B. canis could be achieved when the amplicons of omp2b/2a were detected by B. canis-specific primers, as could the identification of BCSP31 and omp31. If specific amplifications occurred using all pairs of primers, the strain was identified as B. suis. Combinatorial PCR reported here thus appeared to be an ideal method of identifying Brucella spp., the causative pathogen of human brucellosis.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Brucella spp. is a worldwide zoonotic pathogen. Infection by Brucella canis in dogs is endemic in the Southern USA and in Central and South America, but it appears sporadically in other parts of the world, including Europe. Tissue samples from a dog with chronic prostatitis, discospondylitis and locomotor problems were subjected to clinical and laboratory examinations. B. canis was detected by PCR in biological fluids and tissues of the animal, while antibodies to B. canis were found in the serum, providing additional strong evidence for the circulation of B. canis in Italy.
    The New Microbiologica: official journal of the Italian Society for Medical Virology (SIVIM) 10/2010; 33(4):337-41. · 1.67 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Interferon gamma (IFN-gamma) is a pro-inflammatory cytokine playing a pivotal role in the defense mechanism against Brucella infection. The IFN-gamma (+874 A/T in intron 1) TT genotype and +5644 T/A, TT genotype which have been reported to be associated with high IFN-gamma production, were hypothesized to be associated with susceptibility to brucellosis in an Iranian population. Genotyping of the IFN-gamma variants was performed using an Allele-Specific polymerase chain reaction (AS-PCR) method on a total of 281 subjects including 153 patients with active brucellosis and 128 healthy controls. The result of the present study revealed that the +874 minor allele (A) and homozygote genotype (AA) were more frequent in brucellosis patients compared with controls showing a statistically significant difference (OR = 2.588, 95% CI: 1.313-5.104, p= 0.006 for the AA genotype; OR = 1.575, 95% CI: 1.124-2.216, p= 0.010 for the A allele). However, the allelic and genotypic distribution of the IFN-gamma polymorphism at position UTR5644 A > T was not significantly different between patients and controls (P > 0.05). The distribution of haplotypes in our study suggested that the T/A haplotype (+874/UTR5644) with an increased frequency in controls than in patients may protect controls against Brucella infection. Overall, we suggest that IFN-gamma +874 AA genotype and A allele act as risk factors for developing brucellosis infection in our population.
    Microbiology and Immunology 08/2013; · 1.55 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: the blood culture is considered the gold standard, but it presents issues of sensitivity and delay in results. Therefore, the polymerase chain reaction (PCR) could be useful to detect low amounts of bacterial DNA from clinical samples and provide results within hours. Objective: to evaluate the sensitivity and specificity of PCR for the detection of Brucella canis in whole blood samples. Methods: blood samples from 499 dogs from kennels in two Colombian regions and 91 co-inhabiting humans were used. The 2-mercaptoethanol rapid slide agglutination test (2ME-RSAT) from serum and blood culture and PCR tests from whole blood were performed on all samples. Bayes theorem was used to establish the sensitivity and specificity of the PCR test compared with the other tests performed. Results: 9.9% of the evaluated co-inhabiting humans yielded positive serological results and 0% were positive by PCR or blood culture tests. 10.8% of dog samples were positive by blood culture, 19% were positive by PCR and 13% were positive by 2ME-RSAT. 7% of the samples were positive by all tests. Compared with blood culture, PCR had a sensitivity of 92.6% and a specificity of 90% for canine samples. Compared with 2ME-RSAT, it had a sensitivity of 77.4% and a specificity of 89.2%. When PCR and 2ME-RSAT results were compared with blood culture, a higher number of positive samples were retrieved than when results of only individual tests were applied. Conclusions: PCR is useful to detect B. canis in clinical samples; however, it is preferable to include the 2ME-RSAT test, as this ¤improves the accuracy of the diagnosis. The PCR results are obtained within 24 to 48 hours and do not require the presence of whole bacterial cells to detect DNA.
    Revista Colombiana de Ciencias Pecuarias 01/2014; 27:3-11. · 0.20 Impact Factor


Available from